ad

Orchid Pharma (ORCHPHARMA) Share Price Rise: Stock Gains 5.44% Today

16 Nov 2026 • 12:17 pm

Orchid Pharma (ORCHPHARMA) Share Price Rise: Stock Gains 5.44% Today
Orchid Pharma Ltd. (ORCHPHARMA) share price rose to Rs 929.45 today, up 5.44% from the previous close. Market cap was Rs 5,278.88 crore.

Orchid Pharma Share Price stood at Rs 929.45 at 12:07 PM IST on 16 November 2026, up Rs 47.95 or 5.44% from the previous close of Rs 881.50. The company has a market capitalisation of Rs 5,278.88 crore, according to latest Univest data.

The price move is confirmed in Univest data; a company-specific reason has not been established. What the numbers do show is a stock that opened at Rs 951.25, touched a low of Rs 907.10 and a high of Rs 980.00, and was at Rs 929.45 at the time of writing. That makes the Orchid Pharma share price rise one of the Stocks Rising Today entries to examine on Univest.

Orchid Pharma Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 929.45
Previous Close Rs 881.5
Today's Move Rs 47.95 (+5.44%)
Open Rs 951.25
High Rs 980
Low Rs 907.1
Market Capitalisation Rs 5,278.88 crore
Market Cap Category Mid Cap

Orchid Pharma Ltd. (ORCHPHARMA) rose to Rs 929.45 from the previous close of Rs 881.5, a move of Rs 47.95 or 5.44%. The stock opened at Rs 951.25, reached a high of Rs 980, recorded a low of Rs 907.1.

Orchid Pharma Share Price Today is Rs 929.45, a gain of Rs 47.95 or 5.44% over the previous close of Rs 881.50. The stock opened at Rs 951.25, touched a low of Rs 907.10 and a high of Rs 980.00, and last traded at Rs 929.45. Market capitalisation stands at Rs 5,278.88 crore.

The opening price of Rs 951.25 was Rs 69.75 above the previous close, and the day low of Rs 907.10 was Rs 44.15 under the open. The last traded price of Rs 929.45 is Rs 21.80 under the open and Rs 22.35 above the day low.

The gap between the day low and the day high is Rs 72.90, and the last traded price sits Rs 50.55 below the day high of Rs 980.00. These Orchid Pharma Stock Performance figures are as of 12:07 PM IST and will change as trading continues, so the Orchid Pharma Share Price Update below should be read as a snapshot of the midday session.

Price action is only one part of the picture, so the next section looks at the fundamentals behind the stock.

Orchid Pharma Ltd. (ORCHPHARMA) Fundamental Analysis

Metric Value
Market Capitalisation Rs 5,278.88 crore
P/E Ratio 122.81x
P/B Ratio 3.37x
ROE 0.7%
ROCE 1.11%
EPS Rs 7.18
Book Value Per Share Rs 261.65
Dividend Yield 0%

Orchid Pharma Ltd. (ORCHPHARMA) fundamental metrics show P/E 122.81x, P/B 3.37x, ROE 0.7%, ROCE 1.11%. These ratios show where the company stands today and are not a call to buy or sell.

Orchid Pharma Ltd. has a market capitalisation of Rs 5,278.88 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 122.81x, P/B at 3.37x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 0.7% and ROCE of 1.11%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7.18, book value per share of Rs 261.65, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.93x, median ROE of 10.98%, median ROCE of 12.63%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 122.81x
Benchmark Median P/E 30.93x
Benchmark Average P/E 52.22x
Benchmark P/E Range 2.6x to 1,177x
Company P/B Ratio 3.37x
Benchmark Median P/B 2.9x
Company ROE 0.7%
Benchmark Median ROE 10.98%
Company ROCE 1.11%
Benchmark Median ROCE 12.63%
Company Market Capitalisation Rs 5,278.88 crore
Benchmark Median Market Cap Rs 698.04 crore

Orchid Pharma Ltd. (ORCHPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Orchid Pharma Ltd. (ORCHPHARMA) has a P/E ratio of 122.81x, which is above the benchmark median of 30.93x, a difference of +297.06%. A P/E difference of this kind is a reference point rather than a recommendation.

Orchid Pharma Ltd. (ORCHPHARMA) has a ROE of 0.7%, which is below the benchmark median of 10.98%, a difference of -93.62%. Orchid Pharma Ltd. (ORCHPHARMA) has a ROCE of 1.11%, which is below the benchmark median of 12.63%, a difference of -91.21%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,51,290.91 41.15 5.05 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 3,05,014.11 90.7 16.95 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,77,333.2 83.49 9.65 26.76 19.27
Laurus Labs Ltd. LAURUSLABS 1,30,755.56 97.59 21.57 18.31 18.2
Zydus Lifesciences Ltd. ZYDUSLIFE 1,18,802.71 28.42 4.27 19.69 21.39

Orchid Pharma Ltd. (ORCHPHARMA) has a P/E ratio of 122.81x compared with the displayed peer median of 83.49x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 0.7% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 1.11% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Orchid Pharma Ltd. (ORCHPHARMA) has a market capitalisation of Rs 5,278.88 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Orchid Pharma

Orchid Pharma is one of the stocks rising today, and these five verified points frame the move without any recommendation.

  • Price action: Rs 929.45 against a previous close of Rs 881.50, a gain of 5.44%.
  • Day range: an open at Rs 951.25, a day low of Rs 907.10 and a day high of Rs 980.00.
  • Valuation: a P/E of 122.81 against an industry median of 30.93, and a P/B of 3.37 against a median of 2.90.
  • Returns: ROE of 0.70% and ROCE of 1.11%, below the medians of 10.98% and 12.63%.
  • Size: a market capitalisation of Rs 5,278.88 crore against an industry median of Rs 698.04 crore.

About Orchid Pharma

Orchid Pharma Ltd. trades under the symbol ORCHPHARMA and operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry. With a market capitalisation of Rs 5,278.88 crore, it belongs to a same-industry group of 205 companies that includes Sun Pharmaceutical Industries, Divi's Laboratories and Cipla. Further Company Overview details are available on the Univest stock page, while this article sticks to verified price and ratio figures.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is the Orchid Pharma Share Price today?

Ans. Orchid Pharma Share Price was Rs 929.45 at 12:07 PM IST on 16 November 2026, up Rs 47.95 or 5.44% from the previous close of Rs 881.50. The stock opened at Rs 951.25 and has touched a high of Rs 980.00.

Why is the Orchid Pharma stock rising today?

Ans. The price move is confirmed in Univest data; a company-specific reason has not been established. The Orchid Pharma Share Price rose 5.44% to Rs 929.45, and the day range so far runs from Rs 907.10 to Rs 980.00.

What is the market capitalisation behind the Orchid Pharma Share Price?

Ans. Orchid Pharma has a market capitalisation of Rs 5,278.88 crore, according to latest Univest data. Market capitalisation describes company size rather than quality, and it sits above the same-industry median of Rs 698.04 crore across 205 companies.

What is the P/E Ratio of Orchid Pharma?

Ans. The P/E Ratio of Orchid Pharma is 122.81, compared with a same-industry median of 30.93 and an average of 52.22. The P/B Ratio is 3.37 against a benchmark median of 2.90, according to the latest Univest figures.

What are the ROE and ROCE of Orchid Pharma?

Ans. Orchid Pharma reports ROE of 0.70% and ROCE of 1.11%. The same-industry benchmark medians are 10.98% for ROE and 12.63% for ROCE, so both return ratios sit below those reference points, according to latest Univest data.

What are the EPS, book value and dividend yield behind the Orchid Pharma Share Price?

Ans. EPS is Rs 7.18, book value per share is Rs 261.65 and dividend yield is 0.00%. Dividend yield is historical data, not a guide to future payouts, and EPS shows the earnings attributable to each share.

How does the Orchid Pharma Share Price compare with peer valuations?

Ans. Against Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Laurus Labs and Zydus Lifesciences, Orchid Pharma has a P/E Ratio of 122.81 above the peer range of 28.42 to 97.59, and a smaller market capitalisation of Rs 5,278.88 crore.

What is the day range of the Orchid Pharma Share Price Today?

Ans. The stock opened at Rs 951.25, touched a low of Rs 907.10 and a high of Rs 980.00. At 12:07 PM IST it last traded at Rs 929.45, which is Rs 50.55 below the day high.

Track Orchid Pharma Share Price on Univest

Use Orchid Pharma Ltd. (ORCHPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track the Orchid Pharma Share Price live on Univest, along with fundamental ratios, 52-week levels and market insights. Univest brings the P/E Ratio, P/B Ratio, ROE and ROCE together on one page, so the Orchid Pharma Share Price Today can be read against its sector and peers whenever the figures change. Univest also publishes Market Update pages for stocks in the news, with no recommendation attached.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down